Basic Information

Gene symbol MIR132 Synonyms MIRN132, miRNA132, mir-132 Type of gene ncRNA
Gene perturbation-related omics dataset PerturbAtlas | PertOrg
Description microRNA 132

GTO ID GTC2163
Trial ID NCT04045405
Disease Heart Failure
Altered gene miR-132
Therapeutic/Target gene Target gene
TherapyASO
Treatment CDR132L
PhasePhase1
Recruitment statusCompleted
TitlePhase I, Randomized, Double-blind, Placebo-controlled Study to Assess Safety, PK and PD Parameters of CDR132L in Patients With Stable Heart Failure of Ischemic Origin (NYHA 1- 3)
Year2019
CountryUnited Kingdom
Company sponsorCardior Pharmaceuticals GmbH
Other ID(s)CDR132L-FIH01|2019-001291-10
Vector information
VectorNo vector was used

Clinical Result

Cohort1: CDR132L_dose level 1
Administration route intravenous injection
Dosage CDR132L, dose level 1 0.32 mg/kg
Pts 5
Age Adult, Older_Adult
References PMID: 33245749
Cohort2: CDR132L_dose level 2
Administration route intravenous injection
Dosage CDR132L, dose level 2 1 mg/kg
Pts 5
Age Adult, Older_Adult
References PMID: 33245749
Cohort3: CDR132L_dose level 3
Administration route intravenous injection
Dosage CDR132L, dose level 3 3 mg/kg
Pts 5
Age Adult, Older_Adult
References PMID: 33245749
Cohort4: CDR132L_dose level 4
Administration route intravenous injection
Dosage CDR132L, dose level 4 10 mg/kg
Pts 5
Age Adult, Older_Adult
References PMID: 33245749
Cohort5: Saline
Administration route intravenous injection
Dosage Saline, 0.32, 1, 3, or 10 mg/kg body weight
Pts 8
Age Adult, Older_Adult
References PMID: 33245749

Relationship Graph

Overview of Knowledge Graph